Swiss National Bank trimmed its position in Tenet Healthcare Co. (NYSE:THC - Free Report) by 1.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 188,400 shares of the company's stock after selling 2,400 shares during the quarter. Swiss National Bank owned 0.20% of Tenet Healthcare worth $23,782,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. True Wealth Design LLC acquired a new stake in shares of Tenet Healthcare in the 3rd quarter valued at $38,000. WR Wealth Planners LLC grew its stake in Tenet Healthcare by 2,836.4% during the fourth quarter. WR Wealth Planners LLC now owns 323 shares of the company's stock worth $41,000 after buying an additional 312 shares during the last quarter. Smartleaf Asset Management LLC increased its holdings in shares of Tenet Healthcare by 30.5% during the fourth quarter. Smartleaf Asset Management LLC now owns 471 shares of the company's stock worth $59,000 after buying an additional 110 shares in the last quarter. Kestra Investment Management LLC acquired a new position in shares of Tenet Healthcare in the 4th quarter worth approximately $60,000. Finally, Wilmington Savings Fund Society FSB increased its holdings in Tenet Healthcare by 1,352.8% during the 4th quarter. Wilmington Savings Fund Society FSB now owns 523 shares of the company's stock valued at $66,000 after purchasing an additional 487 shares in the last quarter. 95.44% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of analysts have recently weighed in on the company. StockNews.com upgraded Tenet Healthcare from a "hold" rating to a "buy" rating in a research note on Thursday, March 13th. KeyCorp dropped their target price on shares of Tenet Healthcare from $200.00 to $185.00 and set an "overweight" rating for the company in a research note on Tuesday, January 7th. Cantor Fitzgerald reissued an "overweight" rating and set a $177.00 price target on shares of Tenet Healthcare in a research note on Thursday, February 13th. Barclays reduced their price objective on Tenet Healthcare from $190.00 to $161.00 and set an "overweight" rating on the stock in a report on Thursday, February 13th. Finally, The Goldman Sachs Group cut Tenet Healthcare from a "buy" rating to a "neutral" rating and lowered their target price for the company from $196.00 to $140.00 in a research note on Monday, December 16th. Three investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $163.88.
Check Out Our Latest Stock Report on THC
Insider Buying and Selling
In other news, Director J Robert Kerrey sold 9,525 shares of the firm's stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $125.43, for a total value of $1,194,720.75. Following the completion of the transaction, the director now owns 27,378 shares in the company, valued at $3,434,022.54. This trade represents a 25.81 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.93% of the stock is owned by corporate insiders.
Tenet Healthcare Stock Down 2.7 %
Shares of NYSE:THC traded down $3.47 during trading on Friday, hitting $122.87. 6,652,080 shares of the company's stock traded hands, compared to its average volume of 1,507,654. The company has a 50-day moving average price of $132.31 and a 200-day moving average price of $143.71. Tenet Healthcare Co. has a 52 week low of $90.03 and a 52 week high of $171.20. The company has a current ratio of 1.78, a quick ratio of 1.70 and a debt-to-equity ratio of 2.25. The company has a market cap of $11.69 billion, a price-to-earnings ratio of 3.81, a price-to-earnings-growth ratio of 1.02 and a beta of 2.06.
Tenet Healthcare (NYSE:THC - Get Free Report) last issued its quarterly earnings data on Wednesday, February 12th. The company reported $3.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. As a group, research analysts forecast that Tenet Healthcare Co. will post 12.24 EPS for the current fiscal year.
About Tenet Healthcare
(
Free Report)
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
See Also
Before you consider Tenet Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.
While Tenet Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
